1. A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia. (9th June 2020) Authors: Fiedler, Walter; Chromik, Joerg; Amberg, Stefanie; Kebenko, Maxim; Thol, Felicitas; Schlipfenbacher, Vera; Christine Wilke, Anne; Modemann, Franziska; Janning, Melanie; Serve, Hubert; Ganser, Arnold; Bokemeyer, Carsten; Theile, Susann; Deppermann, Ute; Kranich, Anne L.; Heuser, Michael Journal: British journal of haematology Issue: Volume 190:Number 3(2020) Page Start: e169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗